Burden of illness among commercially insured patients with Alzheimer's disease-Reference-Cited by-同舟云学术

Burden of illness among commercially insured patients with Alzheimer's disease

Published:2007-07 Issue:3 Volume:3 Page:204-210
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Joyce Amie T.¹,Zhao Yang²,Bowman Lee²,Flynn Jennifer A.²,Carter Chureen T.¹,Ollendorf Daniel A.¹

Affiliation:

1. PharMetrics Inc (a unit of IMS)WatertownMAUSA

2. Eli Lilly & CoIndianapolisINUSA

Funder

Eli Lilly & Co, Indianapolis, IN

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2007.04.373

Reference22 articles.

1. Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective;Rice D.P.;Am J Manag Care,2001

2. Statistics about Alzheimer's disease. Available at:http://www.alz.org/AboutAD/Statistics.htm. Alzheimer's Association 2004. Accessed September 23 2004.

3. Causes of Alzheimer's disease. Available at:http://www.alzheimers.org/causes.htm. Alzheimer's Disease Education and Referral Center 2004. Accessed September 23 2004.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medicare Advantage enrollment and outcomes of post-acute nursing home care among patients with dementia;Health Affairs Scholar;2024-05-30

2. The Financial Consequences of Undiagnosed Memory Disorders;Staff Reports (Federal Reserve Bank of New York);2024-05

3. Cost of care for Alzheimer’s disease and related dementias in the United States: 2016 to 2060;npj Aging;2024-02-08

4. The Financial Consequences of Undiagnosed Memory Disorders;2024

5. Psychobiological Evaluation of Day Clinic Treatment for People Living With Dementia – Feasibility and Pilot Analyses;Frontiers in Aging Neuroscience;2022-06-30